Related references
Note: Only part of the references are listed.Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge
Christopher P. Karch et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Deciphering the human antigenome
Alessandro Sette et al.
EXPERT REVIEW OF VACCINES (2016)
In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant
Simon D. van Haren et al.
CYTOKINE (2016)
Liposomal adjuvants for human vaccines
Carl R. Alving et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06
John Sidney et al.
IMMUNOGENETICS (2016)
T-cell recognition is shaped by epitope sequence conservation in the host proteome and microbiome
Anne Bresciani et al.
IMMUNOLOGY (2016)
The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference
Thomas Trolle et al.
JOURNAL OF IMMUNOLOGY (2016)
HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses
Daniela Weiskopf et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype
Ruklanthi de Alwis et al.
JOURNAL OF VIROLOGY (2016)
Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing
Giora I. Morozov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans
Cecilia S. Lindestam Arlehamn et al.
PLOS PATHOGENS (2016)
Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove
Curtis McMurtrey et al.
ELIFE (2016)
An ontology for major histocompatibility restriction
Randi Vita et al.
JOURNAL OF BIOMEDICAL SEMANTICS (2016)
Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii
Kamal El Bissati et al.
JCI INSIGHT (2016)
Malaria vaccine based on self-assembling protein nanoparticles
Peter Burkhard et al.
EXPERT REVIEW OF VACCINES (2015)
Automatic Generation of Validated Specific Epitope Sets
Sebastian Carrasco Pro et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice
Camila Figueiredo Pinzan et al.
PLOS ONE (2015)
Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice
Kamal El Bissati et al.
VACCINE (2014)
MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant
Mark T. Orr et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis
Mark T. Orr et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine
Margaret E. McCoy et al.
MALARIA JOURNAL (2013)
Conformation-specific Display of 4E10 and 2F5 Epitopes on Self-assembling Protein Nanoparticles as a Potential HIV Vaccine
Newton Wahome et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
Effects on Immunogenicity by Formulations of Emulsion-Based Adjuvants for Malaria Vaccines
Christopher B. Fox et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Adjuvants for human vaccines
Carl R. Alving et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines
Carl R. Alving et al.
EXPERT REVIEW OF VACCINES (2012)
Toxoplasma gondii HLA-B*0702-restricted GRA720-28 peptide with adjuvants and a universal helper T cell epitope elicits CD8+ T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice
Hua Cong et al.
HUMAN IMMUNOLOGY (2012)
Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine
Stephen A. Kaba et al.
PLOS ONE (2012)
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
David N. Taylor et al.
VACCINE (2012)
Towards an immunosense vaccine to prevent toxoplasmosis: Protective Toxoplasma gondii epitopes restricted by HLA-A*0201
Hua Cong et al.
VACCINE (2011)
Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)
David N. Taylor et al.
VACCINE (2011)
Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults
Christine B. Turley et al.
VACCINE (2011)
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
Ryan C. Anderson et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults
John J. Treanor et al.
VACCINE (2010)
Identification of T-gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans
Tze Guan Tan et al.
VACCINE (2010)
Peptide Nanoparticles as Novel Immunogens: Design and Analysis of a Prototypic Severe Acute Respiratory Syndrome Vaccine
Tais A. P. F. Pimentel et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria
Stephen A. Kaba et al.
JOURNAL OF IMMUNOLOGY (2009)
Why prevent, diagnose and treat congenital toxoplasmosis?
Rima McLeod et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
Susan L. Baldwin et al.
VACCINE (2009)
Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles
Senthilkumar Raman et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2006)
A decaepitope polypeptide primes for multiple CD8+ IFN-γ and Th lymphocyte responses:: Evaluation of multiepitope polypeptides as a mode for vaccine delivery
J Alexander et al.
JOURNAL OF IMMUNOLOGY (2002)
Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
BD Livingston et al.
VACCINE (2001)
Share Paper
